Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
Benign ethnic neutropenia (BEN) is defined as a neutrophil count of <1.5×109 cells/L in healthy individuals and is more common in populations of certain ethnicities, e.g. African or Middle Eastern ethnicity. Neutrophil values are commonly included in eligibility criteria for research participatio...
Main Authors: | Rephaim Mpofu, Kennedy Otwombe, Koleka Mlisana, Maphoshane Nchabeleng, Mary Allen, James Kublin, M Juliana McElrath, Linda-Gail Bekker, Gavin Churchyard, Glenda Gray, Fatima Laher |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0241708 |
Similar Items
-
Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
by: Kathryn L Hopkins, et al.
Published: (2014-01-01) -
HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials
by: Volk JE, et al.
Published: (2012-09-01) -
Where are we going with HIV vaccines?
by: Lynn Morris, et al.
Published: (2010-01-01) -
Where are we going with HIV vaccines?
by: Lynn Morris, et al.
Published: (2010-01-01) -
Where are we going with HIV vaccines?
by: Lynn Morris, et al.
Published: (2010-01-01)